Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Thruvision Group PLC Report Publication Announcement 2021

Nov 11, 2021

7968_rpa_2021-11-11_32a9135d-4aab-4c77-9f98-9cd9656940f1.html

Report Publication Announcement

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 0131S

Thruvision Group PLC

11 November 2021

11 November 2021

Thruvision Group plc

Notice of Interim Results

Thruvision (AIM:THRU), the leading provider of "safe distance" people-screening technology to the international security market, will announce its interim results for the six months ended 30 September 2021 on Monday 22 November 2021.

For further information please contact:
Thruvision Group plc +44 (0)1235 436180
Tom Black, Executive Chairman
Colin Evans, Chief Executive
Investec Bank plc +44 (0)20 7597 5970
James Rudd / Sebastian Lawrence / Patrick Robb
FTI Consulting LLP +44 (0)20 3727 1000
Matt Dixon / Tom Blundell

About Thruvision

Addressing the urgent need for "safe distance" people security screening in the COVID era, Thruvision is uniquely capable of detecting metallic and non-metallic items including weapons, explosives and contraband items that are hidden under clothing, at distances between 3 and 10m. Using patented passive terahertz technology, Thruvision completely removes the need for physical "pat-downs" and has been vetted and approved by the US Transportation Security Administration for surface transportation. Operationally deployed in 20 countries around the world, Thruvision is used for aviation security, retail supply chain loss prevention, customs and border control, and public area security. The company has offices near Oxford, and in Washington DC.

www.thruvision.com 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NORVBLFFFFLXFBF